Clinical Trials on RFS

Total 163 results

Fudan University

Unknown

Bevacizumab Combined With Gefitinib in the Treatment of Advanced NSCLC

PFS

China
Fudan University

Unknown

Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell

PFS

China
Qingdao Central Hospital

Recruiting

Chemotherapy Combines With Bevacizumab and PD-1 Inhibitor in Non-squamous NSCLC

PFS | OS

China
University Children's Hospital Basel

Completed

Human Intestinal Amino Acid Absorption and the Role of a Local RAS

Renin-Angiotensin Aldosterone System (RAS)

Switzerland
University Hospital, Basel, Switzerland

Completed

RAS-Peptide-Profile Study in Healthy Male Subjects (RAS)

RAS Peptide Profile in Healthy Volunteers

Switzerland
Amgen

Completed

Determination of RAS Mutation Status in Liquid Biopsies in Subjects With RAS Wild-type.PERSEIDA Study (PERSEIDA)

RAS Wild Type mCRC

Spain
PepsiCo Global R&D

Completed

Effects of Hydrolyzed Collagen and Vitamin C on Explosive Performance

Collagen Synthesis | Rate of Force (RFD) Development

United States
PD Dr. med. Volker Heinemann
MGO Ruhr-University Bochum (RUB)

Recruiting

Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model (2016-003295-46)

Colo-rectal Cancer | RAS Wild-type | UICC III | UICC II + RF | UICC IV Curative Intent

Germany
Chen Xiaoping

Completed

Postoperative Adjuvant Therapy of HCC Based on PD-1

Hepatocellular Carcinoma | RFS

China
China Medical University, Taiwan
Changhua Christian Hospital

Completed

Heart Rate Variability Assessment in Dialysis Patients by Acupuncture

RLS

Taiwan
Göteborg University
Sahlgrenska University Hospital, Sweden

Completed

Effects of Probiotic VSL#3 on Expression of Small Intestinal Renin-angiotensin System

the Local Renin-angiotensin System (RAS) in Small Intestinal Mucosa in Man

Sweden
Charite University, Berlin, Germany

Recruiting

Repeat Immunoadsorption Post Covid ME/CFS

Post-COVID ME/CFS

Germany
Assiut University

Not yet recruiting

Frailty in Critical Care Unit's Patients

CFS
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Hematological Anomalies in Children With Rasopathy (RAS-HEMATO)

RAS Mutation
Charite University, Berlin, Germany

Recruiting

Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS

ME/CFS | Post-COVID ME/CFS

Germany
Region Stockholm

Not yet recruiting

ROS in TBI Patients in Relation to Level of Oxygenation. (ROS-TBI)

Systemic Oxygenation vs ROS Formation in TBI Patients

Sweden
Charite University, Berlin, Germany
Vivantes Klinikum im Friedrichshain; KLINIK BAVARIA Kreischa

Recruiting

Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS

Post-COVID ME/CFS

Germany
XenoPort, Inc.

Recruiting

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS (RLS)

RLS

United States
Charite University, Berlin, Germany
Bayer

Not yet recruiting

Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome

Post-COVID ME/CFS

Germany
Hospices Civils de Lyon

Unknown

Stimulate the Face to Improve Tactile Acuity on the Hand (FACEHAND)

Stroke | Face | RSS

France
Chinese PLA General Hospital
Gansu Provincial Maternity and Child-Care Hospital

Unknown

Mesenchymal Stem Cell-derived Pleiotropic Factor in Treating Poorly Healed Wounds of Postoperative Incision

MSCs-PFs in Treating Poorly Healed Wounds of Postoperative Incision
Henrik Axel Verder
Odense University Hospital; Aarhus University Hospital Skejby; Rigshospitalet... and other collaborators

Completed

Determination of Lung Maturity and Prediction of RDS at Birth

Premature Birth | RDS

Denmark
University of Padova

Not yet recruiting

Dexmedetomidine for LISA Procedure in Preterm Infants (DEXLISA)

RDS

Italy
Sun Yat-sen University

Unknown

Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer (SYSGO-003)

Quality of Life | PFS | OS

China
National Institute of Nursing Research (NINR)

Recruiting

Patient-Centered Assessment of Symptoms and Outcomes

Cancer | Fatigue | Lupus | CFS | ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Systemic Lupus Erthematosus | Sjogrens

United States
University Hospital, Linkoeping

Completed

Frailty Screening in the Swedish Emergency Department Setting

Frailty | Frailty Syndrome | Emergency Department | Geriatric Assessment | CFS

Sweden
Pasithea Therapeutics Corp.

Recruiting

PAS-004 in Patients With Advanced Solid Tumors

Advanced Solid Tumors | RAS Mutation | NF1 Mutation | RAF Mutation

United States
Mundipharma Research GmbH & Co KG

Completed

Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms

Moderate to Severe Idiopathic RLS With Daytime Symptoms

Spain, Sweden, Germany
Vilnius University

Recruiting

Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT

Respiratory Failure | RDS of Prematurity | Prematurity | Very Low Birth Weight Infant | RDS - Infants

Lithuania
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Safety and Efficacy of Oral Etoposide Combined With Antirotinib and Envollizumab in Elderly Patients With Lung Cancer

Progression Free Survival(PFS)
XenoPort, Inc.

Recruiting

An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS (RLS)

RLS

United States
Practitioners Alliance Network

Unknown

Treatment of CFS and Fibromyalgia With HRG 80 Red Ginseng

Fibromyalgia | CFS

United States
XenoPort, Inc.

Withdrawn

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS (RLS)

RLS

United States
Practitioners Alliance Network

Unknown

Treatment of Fibromyalgia and CFS With Ribose, Ashwagandha, Rhodiola, Licorice, Schisandra and Green Tea Extract

Fibromyalgia | CFS

United States
Laibin People's Hospital

Completed

A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer

The Primary Study Metric is Progression-free Survival (PFS)
Beth Israel Medical Center

Completed

A Multi-Site Study of Music Therapy Interventions on Vitals, Feeding and Sleep in Premature Infants

Sepsis | Prematurity | RDS | SGA
Centre Hospitalier Intercommunal Creteil

Completed

Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1 (BRIGAROS)

Lung Cancer ROS Translocated

France
Sidnei Epelman

Unknown

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Refractory or Relapsed RMS and Soft Tissue Sarcomas

Brazil
Nested Therapeutics, Inc

Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors (NST-628)

Glioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene Mutation

Australia
University Hospital, Clermont-Ferrand

Completed

Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)

Protective Lung Ventilation Using: | Low Tidal Volume (6-8 mL/kg Predicted Body Weight) | PEEP of 6-8 cmH2O | Intraoperative RMs

France
Technical University of Munich
German Cancer Research Center; Helmholtz Munich, Munich; Charité University Hospital...

Recruiting

Munich ME/CFS Cohort Study (MUC-CFS)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)

Germany
Beijing Hospital
Bethune Charitable Foundation

Recruiting

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Metastatic Colorectal Cancer | MSS | RAS Mutation

China
Chinese PLA General Hospital

Recruiting

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

Colorectal Neoplasms | Colorectal Cancer | Microsatellite Stable Colorectal Carcinoma | RAS Mutation

China
TG Therapeutics, Inc.

Active, not recruiting

An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis (RMS)

United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
Merck KGaA, Darmstadt, Germany

Completed

Effects of Cladribine Tablets on the PK of Microgynon®

Relapsing Multiple Sclerosis (RMS)

Germany, Poland
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) (ULTIMATE II)

Relapsing Multiple Sclerosis (RMS)

United States
iOMEDICO AG
Amgen

Completed

Validation of a New Prognostic Score for Adult Patients With RAS Wild-type mCRC Treated With Vectibix® and FOLFIRI or FOLFOX in First Line (VALIDATE) (VALIDATE)

Metastatic Colorectal Cancer | RAS Wild-type

Germany
Amgen

Completed

Observational Study of Vectibix With Chemotherapy for Metastatic Colorectal Cancer Patients

Wild-type RAS Metastatic Colorectal Cancer
University of Campania "Luigi Vanvitelli"

Completed

Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | RAS Wild Type

Italy
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 ) (ULTIMATE 1)

Relapsing Multiple Sclerosis (RMS)

United States

Clinical Trials on RFS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations